In this setup, sulforaphane did not protect tumor cells; instead, it increased the effect of gemcitabine, cisplatin, doxorubicin, 5-fluorouracil, sorafenib, and TRAIL [20,22,23,27]. The gene discussed is TNFSF10; the disease is neoplasm.